Share this:
Participating Companies at Biotech Showcase™ 2012
Biotech Showcase™ attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.
0-9AB CDE FGH IJ K LMN OPQ RST UVW XYZ
| Number of companies: 892 | |
| 0-9 | Top of Page |
| 137 Ventures | United States |
| 2B BlackBio S.L. | Spain |
| 4s3 Bioscience | United States |
| 4SC | Germany |
| 5AM Ventures | United States |
| A | Top of Page |
| Aagami, Inc. | United States |
| Aastrom Biosciences | United States |
| Abbott | United States |
| AbGenomics International Inc. | United States |
| Abingworth Management Inc. | United States |
| Accelovance | United States |
| Aceras BioMedical LLC | United States |
| ActoGeniX NV | Belgium |
| Acurian | United States |
| Adaptimmune Ltd | United Kingdom |
| Addex Pharmaceuticals | Switzerland |
| Adenium Biotech | Denmark |
| Adeona Pharmaceuticals, Inc. | United States |
| Adimab, LLC | United States |
| Adjuvant Partners | United States |
| ADOCIA | France |
| AdoTube, Inc. | United States |
| Advamed | United States |
| AdvaMedDx | United States |
| Advanced BioHealing (Shire) | United States |
| Advanced Cell Technology, Inc. | United States |
| Advancell | Spain |
| AdvanDx | United States |
| Advantar Labs | United States |
| Advinus Therapeutics Ltd. | India |
| Advocates Pharmaceutical & Healthcare | United Kingdom |
| Aegis Capital | United States |
| Aescap Venture | Netherlands |
| Aesica Pharmaceuticals Ltd | United States |
| Aethlon Medical | United States |
| Affimed Therapeutics AG | Germany |
| Agilent Technologies, Inc. | United States |
| Agility Capital | United States |
| Aglaia Biomedical Ventures BV | Netherlands |
| AGW Group LLC | United States |
| AiroMedica LLC | United States |
| Aisling Capital | United States |
| Akexander Antonopoulos | United States |
| Albany Molecular Research Inc. | United States |
| Albemarle Corp. | United States |
| Aldagen | United States |
| Alethia Biotherapeutics | Canada |
| Alexion Pharmaceuticals | United States |
| Alfred Blaikie | United States |
| Allara Therapeutics, Inc. | United States |
| Alliance for Regenerative Medicine | United States |
| AlloCure | United States |
| Alopexx Enterprises, LLC | United States |
| AlphaCore Pharma | United States |
| AlphaVax | United States |
| Alphora Research Inc. | Canada |
| Alquest Therapeutics | United States |
| Alta Partners | United States |
| AltheaDx, Inc. | United States |
| Altiris Therapeutics, Inc. | United States |
| AmorChem | Canada |
| Anchor Therapeutics | United States |
| Anergis SA | Switzerland |
| Anteo Dx | Australia |
| Antisense Pharma GmbH | Germany |
| Apelles Investment Management | United States |
| Apjohn Ventures | United States |
| Applied Immune Technologies | Israel |
| Apposite Capital | United Kingdom |
| Apricus Biosciences, Inc. | United States |
| Aptalis Pharmaceutical Technologies | United States |
| Aqua Partners LLC | United States |
| Aquapharm Biodiscovery Ltd | United Kingdom |
| Aradigm Corporation | United States |
| Arcion Therapeutics Inc | United States |
| ARIZONA TECHNOLOGY INVESTOR FORUM | United States |
| Ark Therapeutics plc | United Kingdom |
| Arnold & Porter LLP | United States |
| Array Capital, LLC | United States |
| Arsenal Capital Partners | United States |
| Asahi Kasei Corporation | Japan |
| Ascendiant Capital | United States |
| ASEBIO - Spanish Bioindustry Association | Spain |
| Ash Stevens, Inc. | United States |
| Ashford Capital Management | United States |
| Asmacure Ltee | Canada |
| Aspire Capital | United States |
| Aspire Therapeutics | United States |
| AssureRx Health, Inc. | United States |
| Astex Pharmaceuticals | United States |
| AstraZeneca | United States |
| Atheln, Inc. | United States |
| Athena | United States |
| Athena Bioventures | United States |
| Athera Biotechnologies AB | Sweden |
| Athersys, Inc. | United States |
| Athyrium Capital Management | United States |
| Atlas Monsanto Seed Fund Alliance | United States |
| Atlas Venture, Inc. | United States |
| Atossa Genetics, Inc. | United States |
| Atox Bio | Israel |
| Aurora Capital LLC | United States |
| AusBiotech Ltd | Australia |
| Ausio Pharmaceuticals, LLC | United States |
| Auxol Capital, LLC | United States |
| Avalere Health | United States |
| AVAX Technologies, Inc. | United States |
| Avaxia Biologics | United States |
| AvidBiotics Corp. | United States |
| AVM Biotechnology | United States |
| Axial Biotech | United States |
| AxoGen, Inc. | United States |
| B | Top of Page |
| Bailard, Inc | United States |
| Baillard | United States |
| Band of Angels | United States |
| Barney & Barney LLC | United States |
| Base Pair Communications | United States |
| Baxter | United States |
| Baxter Ventures | United States |
| Bay Bio | United States |
| Bay Biotech Consulting | United States |
| Bay City Capital | China |
| Bayer HealthCare AG | Germany |
| BB Biotech Ventures | Switzerland |
| BCC Partners | United States |
| BDC Venture Capital | Canada |
| Becton Dickinson | United States |
| Bell Biosystems, Inc. | United States |
| Bill & Melinda Gates Foundation | United States |
| Bio-Path Holdings, Inc. | United States |
| BioAdvance | United States |
| BioBDx | United States |
| Biocat | Spain |
| BioCentury Publications | United States |
| Biocodex USA | United States |
| BIOCOM | United States |
| Biodesix | United States |
| BioDuro, A PPD Company | China |
| BioGeneration Ventures | Netherlands |
| BiologicsMD | United States |
| Biomay AG | Austria |
| BioMed Reports | United States |
| BIOMEDAL | Spain |
| BioMedPartners AG | Switzerland |
| BioMedTracker | United States |
| Bioneer Corp. | Korea, South |
| Bionomics Ltd | Australia |
| BioPharm Insight | United States |
| BioPharm Strategies | United States |
| BiOptix Diagnostics, Inc. | United States |
| BioQuest | United States |
| Biosearch | United States |
| BIOTECanada | Canada |
| Biotech Innovations | Chile |
| Biotechnology Entrepreneur and Angel Investor | United Kingdom |
| Biotechnology Growth Trust plc | United Kingdom |
| Biotecnol, Inc | United States |
| Biotica Technology Ltd. | United Kingdom |
| BioTime | United States |
| Biotron Limited | Australia |
| BioVectra Inc. | Canada |
| BioWorld | United States |
| BladeRock Capital | United States |
| BMRC-Chile | Chile |
| BNBuilders | United States |
| Boehringer Ingelheim | United States |
| Brandon Capital Partners | Australia |
| Bridgehead International | United States |
| Brinson Patrick Securities Corporation | United States |
| Burrill & Company | United States |
| C | Top of Page |
| C14 Consulting Group | United States |
| Caledonia Capital Partners, LLC | United States |
| California Technology Report | United States |
| Caltherix Inc. | United States |
| Calvert Research | United States |
| Cambrex Corp. | United States |
| Cambridge Healthtech Institute | United States |
| Cambridge Imaging | United Kingdom |
| Campbell Alliance | United States |
| Canaan Partners | United States |
| CanBex Therapeutics Ltd | United Kingdom |
| Capital Midwest | United States |
| Capital Royalty L.P. | United States |
| Cardium Therapeutics | United States |
| Cardoz AB | Sweden |
| Care Capital | United States |
| Carhill Capital | United States |
| Catalysis Capital Partners Ltd. | United Kingdom |
| Catalyst Healthcare Consulting | United States |
| Cato BioVentures | United States |
| CBT Advisors | United States |
| CD Diagnostics | United States |
| CDIB Bioscience Ventures | United States |
| CDRD Ventures | Canada |
| Cell Therapy Blog | United States |
| Cellastra Inc | United States |
| Cellmid Limited | Australia |
| Celtic Pharma Holdings A | United Kingdom |
| Cendalor Partners LLC | United States |
| CeNeRx BioPharma | United States |
| Cerecor Inc. | United States |
| Cevec Pharmaceuticals GmbH | Germany |
| Charter Life Sciences | United States |
| Chembio Diagnostics Inc. | United States |
| Chilton Capital Management | United States |
| ChinaBio LLC / ChinaBio Capital Partners | United States |
| ChinaBio Today | United States |
| Chiral Capital | United States |
| ChromaDex Inc. | United States |
| Circadian Technologies Limited | Australia |
| CiToxLAB North America | Canada |
| Claremont Creek Ventures | United States |
| Clark & Elbing LLP | United States |
| Clearity Foundation | United States |
| Clinical Network Services (CNS) Pty Ltd | Australia |
| CM Capital Investments | Australia |
| Coalescence Inc. | United States |
| Cognition Therapeutics Inc. | United States |
| Colby Pharma | United States |
| College Hill | United Kingdom |
| CoLucid Pharmaceuticals, Inc. | United States |
| Columbia Laboratories, Inc. | United States |
| Communications Strategy Group Inc. | United States |
| Compendia Bioscience | United States |
| Complexa, Inc. | United States |
| Consulate General of Switzerland | United States |
| Cook Williams Communications | United States |
| Corden Pharma International | United States |
| Coronado Biosciences, Inc. | United States |
| Cortical Dynamics Ltd | Australia |
| Covagen AG | Switzerland |
| Covington & Burling LLP | United States |
| CPR Pharma Services Pty Ltd | Australia |
| Creative Strategies | United States |
| Credit Agricole Private Equity | France |
| Cristal Delivery | Netherlands |
| Critical Outcome Technologies Inc. | Canada |
| Crossfields Capital Management | United States |
| Cryoport, Inc. | United States |
| Crystal Research | United States |
| CTI | United States |
| CTI Life Science Fund | Canada |
| Curemark | United States |
| CytomX Therapeutics | United States |
| Cytori Therapeutics, Inc. | United States |
| CYTRX CORPORATION | United States |
| D | Top of Page |
| Dalton Pharma Services | Canada |
| DATATRAK International | United States |
| Dawson James Securities, Inc. | United States |
| DCLS | United States |
| Debiopharm SA | Switzerland |
| Decheng Capital | China |
| Deerfield | United States |
| DEFTA PARTNERS | United States |
| Delenex Therapeutics AG | Switzerland |
| Delmar Chemicals Inc. | Canada |
| DELPHI GENETICS | Belgium |
| Delpor, Inc. | United States |
| Demy-Colton Life Science Advisors | United States |
| Dendreon | United States |
| Depomed, Inc | United States |
| Desert Angels | United States |
| Deutsche Bank AG | Germany |
| DFA Consulting | United States |
| DiagnoCure inc. | Canada |
| DIGNA Biotech | Spain |
| Dillon Capital Strategies | United States |
| Dithera Inc. | United States |
| DJK BioConsult | United States |
| DLVR Therapeutics Inc. | Canada |
| Domainex | United Kingdom |
| Dovedale Investments | United States |
| Dr. Reddy's CPS | United States |
| DSM Venturing | Netherlands |
| DxS - a QIAGEN company | United States |
| E | Top of Page |
| e-Therapeutics plc | United Kingdom |
| Easton Capital | United States |
| EBD Group | United States |
| Echo Therapeutics, Inc. | United States |
| Echogen Inc. | United States |
| Ecoeos | United States |
| Edge Group | United States |
| Edwards Wildman | United States |
| Eli Lilly | China |
| Elsevier Business Intelligence | United States |
| Elusys Therapeutics, Inc. | United States |
| EMBL Ventures | Germany |
| EMD Millipore | United States |
| Emerald BioStructures | United States |
| Enterome Bioscience | France |
| Entrepreneurs Fund | United Kingdom |
| Eon Ventures | United States |
| EpiCept Corporation | United States |
| Epinex Diagnostics, Inc. | United States |
| Era Consulting (UK) Ltd | United Kingdom |
| Ernst & Young LLP | United States |
| ESC Advisors | United States |
| Esoterix Clinical Trials Services | United States |
| Esperante | United Kingdom |
| Etubics Corporation | United States |
| EvaluatePharma USA, Inc. | United States |
| EvoRx Tech, Inc. | United States |
| Evozym Biologics | United States |
| Exact Sciences Corporation | United States |
| Exponent | United States |
| F | Top of Page |
| FAB Pharma | France |
| Fast Forward/National MS Society | United States |
| FasterCures | United States |
| FGK Clinical Research GmbH | Germany |
| Fibralign | United States |
| Fidelity Growth Partners Asia | China |
| FIDES PHARMA SPA | Italy |
| First Island Capital | United States |
| Flatley Management Co. | United States |
| Florida Biologix | United States |
| FluGen Inc. | United States |
| Foley Hoag LLP | United States |
| Forbion Capital Partners | Netherlands |
| Fountain Healthcare Partners | United States |
| Freehills Patent & Trade Mark Attorneys | Australia |
| FreeMind Group | United States |
| Frontline BioVentures | China |
| Frost and Sullivan | United States |
| Future Diagnostics | Netherlands |
| G | Top of Page |
| Galena Biopharma | United States |
| Gallus BioPharmaceuticals, LLC | United States |
| Garphi Biosciences Private Limited | India |
| GBP Capital | United States |
| GBS Venture Partners | Australia |
| GE Capital - Life Sciences | United States |
| Genesys Capital | Canada |
| Genetics Policy Institute | United States |
| GENFIT | France |
| Genocea Biosciences, Inc. | United States |
| GenomeWeb News Daily News | United States |
| Genomic Expression | United States |
| genoway | France |
| Genscript USA Inc. | United States |
| GenSpera, Inc. | United States |
| GenturaDx | United States |
| Genzyme, a Sanofi company | United States |
| GHL | Philippines |
| GL CHEMTEC INTERNATIONAL | Canada |
| Gllion | China |
| Global Clinical Research | France |
| Global Connectworks Ltd. | Canada |
| GlycoMimetics, Inc. | United States |
| Glycotex | United States |
| GlycoVaxyn AG | Switzerland |
| GMS Biotech | United States |
| goBalto, Inc. | United States |
| Goldman Sachs | United States |
| Gray Strategic Advisors, LLC | United States |
| GreenField | United States |
| Griffin Securities | United States |
| Growthworks Capital Ltd | Canada |
| GVK BIO INC | United States |
| H | Top of Page |
| Haemostatix Ltd | United Kingdom |
| Halloran Consulting Group | United States |
| Halo Bioconsulting Ltd | United Kingdom |
| Halteres Associates, LLC | United States |
| Hamilton BioVentures | United States |
| Harvard Bioscience | United States |
| Hatteras Venture Partners | United States |
| Hawaii Biotech | United States |
| HBM Partners AG | Switzerland |
| hca | United States |
| Health Decisions | United States |
| Healthpoint Biotherapeutics | United States |
| Heat Biologics | United States |
| HeathTech Capital | United States |
| Helix Management | United States |
| Helsinn Advanced Synthesis | Switzerland |
| Helsinn Healthcare SA | Switzerland |
| Hepregen Corporation | United States |
| Heritage Partners | United States |
| Holland & Knight, LLP | United States |
| Horizon Technology Finance | United States |
| Hospira Inc | United States |
| Hovione | Portugal |
| HungaroTrial | Hungary |
| Hybrigenics | France |
| Hyde Park Media | United States |
| I | Top of Page |
| I-Bankers Securities | United States |
| IBS Group | United States |
| IDSC | United States |
| Ikaria, Inc. | United States |
| Immudyne, Inc. | United States |
| IMMUNE Pharmaceuticals | United States |
| Immune Targeting Systems (ITS) Ltd | United Kingdom |
| Immune Tolerance Network | United States |
| ImmunoCellular Therapeutics Ltd. | United States |
| Immunocore Ltd | United Kingdom |
| ImmunoGenetix | United States |
| Immunome, Inc. | United States |
| Immunomic Therapeutics, Inc. | United States |
| Immunovaccine Inc. | Canada |
| Imperial Innovations | United Kingdom |
| Imprimatur Capital | United Kingdom |
| inc Research | United States |
| Incozen Therapeutics | Switzerland |
| Index Ventures | Switzerland |
| India Times | India |
| IndiPharm, Inc. | United States |
| Infinity Venture Group | United States |
| InflammaGen Therapeutics | United States |
| Inkef Capital | Netherlands |
| Innate Immunotherapeutics | New Zealand |
| Innotrove, LLC | United States |
| Innoven Partenaires | France |
| Inova Software | United States |
| Inovation Ventures | United States |
| Inovio Pharmaceuticals Inc. | United States |
| Integrated Magnetic Systems Ltd | United Kingdom |
| IntelGenx Technologies Corp. | Canada |
| IntelliCell BioSciences, Inc. | United States |
| Intellipharmaceutics International Inc. | Canada |
| Intellivest Securities Research | United States |
| Interleukin Genetics, Inc. | United States |
| International Enterprise Singapore | United States |
| International Venture Fund | United States |
| Intersouth Partners | United States |
| InVasc Therapeutics, Inc. | United States |
| Inventages Venture Capital | United Kingdom |
| Invest Securities | France |
| Invetech, Inc | United States |
| InVivo Therapeutics Corp | United States |
| IP Medical Capital | United Kingdom |
| IPQ Analytics, LLC | United States |
| Isconova | Sweden |
| ISTO Technologies, Inc. | United States |
| J | Top of Page |
| JAFCO Life Science Investment | United States |
| Janssen | United States |
| JDM Capital | Australia |
| JDRF Ventures | United States |
| Jennerex Biotherapeutics | United States |
| Jida International Consulting, LLC. | China |
| Jina Ventures Inc. | United States |
| JMJ Financial | United States |
| Johns Hopkins University | United States |
| Johnson & Johnson Development Corp | United States |
| Johnston Associates, Inc. | United States |
| Joseph Grigoli | United States |
| JSDC, Inc. | United States |
| JSR Micro | United States |
| JT Pharma | United States |
| K | Top of Page |
| K2 BioVentures | United States |
| Kalos Therapeutics, Inc | United States |
| Karus Therapeutics Ltd | United Kingdom |
| Katan Associates | United States |
| KCAS | United States |
| Kempen & Co | Netherlands |
| Kenta Biotech Ltd | Switzerland |
| KineMed Inc. | United States |
| Kingsbridge | United States |
| Knowles Electronics | United States |
| Kolon Life Sciences, Inc | Korea, South |
| KOM Capital Management | United States |
| Korea Health Industry Development Institute(KHIDI) | Korea, South |
| Koronis Pharmaceuticals | United States |
| KPCB | United States |
| KPMG AG | Switzerland |
| Kureczka/Martin Associates | United States |
| L | Top of Page |
| Laboratorios Alpha San Ignacio Pharma S.L. | Spain |
| Ladenburg | United States |
| Ladenburg Thalmann & Co. Inc. | United States |
| Laidlaw | United States |
| Landmark Angels, Inc. | United States |
| Laser Pharmaceuticals | United States |
| Laurence Stewart | United States |
| LaVoie Group | United States |
| LD MICRO | United States |
| Ledgemont Capital Group | United States |
| Legend Merchant Group | United States |
| Lentigen Corporation | United States |
| Levin and Company | United States |
| LH Financial Services Corp | United States |
| Life Length | Spain |
| Life Science Angels | United States |
| Life Science Leader magazine | United States |
| Life Sciences Queensland Limited | Australia |
| LifeScan Inc. | United States |
| LifeTech Capital | United States |
| Ligand | United States |
| Lincap Management Co. Inc. | United States |
| Lincoln Park Capital | United States |
| Linkage Biosciences | United States |
| Linnden Communications | United States |
| Lipocine Inc. | United States |
| little gem Life sciences fund | United States |
| Live Leaf | United States |
| Livingston Securities | United States |
| Locust Walk Partners, LLC | United States |
| Logical Ventures | United States |
| Lonza | United States |
| Lowenstein Sandler PC | United States |
| Loxbridge Research LLP | United Kingdom |
| LRM | Belgium |
| Lumira Capital | United States |
| LVP | United States |
| Lypro Biosciences, Inc. | United States |
| Lytix Biopharma AS | Norway |
| M | Top of Page |
| M. D. Anderson Cancer Center | United States |
| M.M. Dillon & Co. | United States |
| MabVax Therapeutics, Inc. | United States |
| Madrigal Pharmaceuticals | United States |
| Magellan Global Partners | United States |
| Magis Capital | United States |
| Malaysian Biotechnology Corporation | Malaysia |
| Marina Biotech, Inc. | United States |
| Martha E. Freitag Consulting LLC | United States |
| MassBio | United States |
| MaxCyte, Inc. | United States |
| MBio Diagnostics, Inc. | United States |
| McGeever LLC | United States |
| MDM Worldwide Solutions | United States |
| MDxHealth | United States |
| Medco Research Institute | United States |
| Medical Technology Stock Letter | United States |
| MediGen Group | United States |
| MedImmune Ventures | United States |
| Meiji Seika Pharma Co., Ltd. | United States |
| Mentrik Biotech, LLC | United States |
| Merck | United States |
| Merck Serono S.A | Switzerland |
| Mercury Equity Group | United States |
| Meridian Life Science, Inc. | United States |
| MERIEUX DEVELOPPEMENT | France |
| Merlin Nexus | United States |
| Merus | Netherlands |
| Mesoblast Limited | Australia |
| Metabolon, Inc. | United States |
| MetaSignal Therapeutics Inc. | Canada |
| Michael J. Fox Foundation for Parkinson's Research | United States |
| Michigan Life Therapeutics | United States |
| Microphama Limited | Canada |
| Midatech USA | United States |
| Mirador Strategies Inc. | United States |
| Miragen Therapeutics, Inc. | United States |
| Mirimus, Inc. | United States |
| Mirna Therapeutics Inc. | United States |
| Mission Bay Capital | United States |
| Mitsubishi Tanabe Pharma America, Inc. | United States |
| Mitsui & Co. Global Investment Ltd. | Japan |
| MLV & Co. | United States |
| Mochida Pharmaceutical Co., Ltd. | Japan |
| Mohr Davidow | United States |
| Molumphy Capital Mgt | United States |
| Montogmery County | United States |
| Morrison & Foerster | United States |
| MP Healthcare Venture Management, Inc. | United States |
| MPM Capital | United States |
| MSDx, Inc. | United States |
| MSK Pharma | United States |
| Mucosis BV | Netherlands |
| Mudan Associates | United States |
| Multimeric Biotherapeutics, Inc. | United States |
| Mustang Ventures | China |
| MVM Life Science Partners LLP | United Kingdom |
| MVP Capital Partners | United States |
| Mymetics Corporation | Switzerland |
| Myocept Inc. | United States |
| MYR GmbH | Germany |
| N | Top of Page |
| NanoDimension | United States |
| NanoSight | United Kingdom |
| Nanotherapeutics Inc | United States |
| National Research Centre | Egypt |
| Natrix Separations | Canada |
| Nature | United Kingdom |
| Navidea Biopharmaceuticals, Inc. | United States |
| NDI Capital | Canada |
| Nebens/Laurence wealth management Group | United States |
| NeoGenomics, Inc. | United States |
| NeoStem Inc | United States |
| Neovacs | France |
| Nerve Access | United States |
| Neuralstem, Inc. | United States |
| Neurocrine Biosciences | United States |
| NeuroGeneration, Inc. | United States |
| NeuroInsights | United States |
| NeuroPerspective | United States |
| Neurotez, Inc. | United States |
| New Biology Ventures | United States |
| Newbridge Consulting Group | United States |
| NewGen Therapeutics, Inc. | United States |
| NewLink Genetics | United States |
| Newstar Ventures Ltd | United States |
| NexImmune, Inc. | United States |
| Nextstar Ventures | United States |
| NGN Capital | Germany |
| Nickel Bio-Ventures, Inc | United States |
| Nordcon Capital | United States |
| North Bay Angels | United States |
| NovaBay Pharmaceuticals | United States |
| Novartis | United States |
| Novitas Capital | United States |
| Novo A/S | Denmark |
| Novo Nordisk A/S | Denmark |
| Numoda Capital Innovations LLC | United States |
| NuPathe | United States |
| Nutter, McClennen & Fish | United States |
| NX PharmaGen Inc | United States |
| O | Top of Page |
| OBI Capital | United States |
| OCT Group LLC | United States |
| Oculus Innovative Sciences, Inc. | United States |
| Ohr Pharmaceutical Inc | United States |
| Omega Funds | United Kingdom |
| Omnia Biologics, Inc. | United States |
| Omnia Molecular | Spain |
| OncBioMune, LLC | United States |
| Oncolix, Inc. | United States |
| Onconova Therapeutics Inc | United States |
| OnCore | United States |
| OncoSec Medical Inc. | United States |
| Onelife Advisors SA | Switzerland |
| ONO Pharma USA | United States |
| Oppenheimer & Co.,Inc | United States |
| Oragenics | United States |
| Organogenesis | United States |
| Organovo, Inc. | United States |
| Orphan Europe | France |
| Ovamed GmbH | Germany |
| Oxford BioMedica plc | United Kingdom |
| Oxford Finance | United States |
| Oxford Finance LLC | United States |
| P | Top of Page |
| Pac-Link BioVentures | United States |
| Pacific Edge Limited | New Zealand |
| Pacific Horizon Ventures | United States |
| Palau Pharma | Spain |
| Palobiofarma | Spain |
| Panorama Capital | United States |
| Paperboy Ventures LLC | United States |
| Pappas Ventures | United States |
| Parco Tecnologico Padano Srl | Italy |
| ParinGenix, Inc. | United States |
| Parvus Therapeutics Inc. | Canada |
| Paul Capital | United Kingdom |
| PBI, International | United States |
| PepTech Corp | United States |
| Peregrine Pharmaceuticals, Inc. | United States |
| Pfizer Inc | United States |
| PGSF II | Korea, South |
| PharmAbcine, Inc. | Korea, South |
| PharmaCell B.V. | Netherlands |
| Pharmaceutical Resource Group | United States |
| PharmacoFore, Inc. | United States |
| PharmaForm | United States |
| Pharmatek Laboratories, Inc. | United States |
| Phases123 LLC | United States |
| Phenomenome Discoveries Inc. | Canada |
| Physician Crossroads | United States |
| PICO | United States |
| Piramal Healthcare (Canada) Limited | Canada |
| PlantForm Corporation | Canada |
| PolyBatics | New Zealand |
| PolyPeptide Group | United States |
| PolyTechnos Venture-Partners | Germany |
| PolyTherics Ltd | United Kingdom |
| POSCO BioVentures | Korea, South |
| Pressure BioSciences, Inc. | United States |
| PRIAXON AG | Germany |
| Prima BioMed Ltd | Australia |
| Prism Ideas Ltd | United Kingdom |
| Proactiveinvestors Group | United States |
| Profectus BioSciences, Inc. | United States |
| ProFibrix | Netherlands |
| Progenitor Cell Therapy | United States |
| Prognomix Inc. | Canada |
| ProMed Partners | United States |
| ProMetic Life Scienses Inc. | Canada |
| Promosome LLC | United States |
| ProQuest Investments | United States |
| ProtAffin AG | Austria |
| Protagonist Therapeutics Inc. | United States |
| PsiOxus Therapeutics Ltd | United Kingdom |
| Pullan Consulting | United States |
| Pulmotect, Inc. | United States |
| Q | Top of Page |
| Q Therapeutics, Inc | United States |
| Qiagen | China |
| Quantum Method | United States |
| Quantummethod | United States |
| Queensland Government | Australia |
| Queensland Investment Corporation | Australia |
| Quest Management | Belgium |
| R | Top of Page |
| R&R Ventures LLC | United States |
| Rahat And Company | Pakistan |
| Raygent Associates | United States |
| Real Endpoints | United States |
| Recordati S.p.A. | Italy |
| Rediens | United States |
| Redsky Partners LLC | United States |
| Regeneron Pharmaceuticals | United States |
| Regenesance B.V. | Netherlands |
| rel-MD, Inc. | United States |
| ReNeuron Group plc | United Kingdom |
| Repros Therapeutics (RPRX) | United States |
| Reset Therapeutics, Inc. | United States |
| Resverlogix Corp. | Canada |
| RhinoCyte, Inc. | United States |
| Riboxx GmbH | Germany |
| Ritter Pharmaceuticals, Inc. | United States |
| Rose Springs | United States |
| Rosetta Capital Ltd | United Kingdom |
| Royal College of Surgeons in Ireland | Ireland |
| RRD International, LLC | United States |
| Russo Partners LLC | United States |
| RxGen, Inc. | United States |
| S | Top of Page |
| S. Jordan Associates | United States |
| Safeguard Scientifics | United States |
| Saladax Biomedical, Inc. | United States |
| SalesForce4Hire | United States |
| SALIENT PHARMACEUTICALS | United States |
| San Francisco Business Times | United States |
| SanBio | United States |
| Sand Hill Angels | United States |
| Sanifit | Spain |
| Sanofi | United States |
| Santhera Pharmaceuticals | Switzerland |
| Savara | United States |
| SB Life Science Equity Managment | United States |
| SCHOTT North America, Inc. | United States |
| Science Futures | United States |
| Scottish Development International | United States |
| Scottish Enterprise | United Kingdom |
| SDL Ventures, LLC | United States |
| Seachaid Pharmaceuticals | United States |
| Seaside Financial & Insurance Serivces | United States |
| Security Research Associates | United States |
| Seed-one Ventures | United States |
| Selecta Biosciences | United States |
| Selexis SA | Switzerland |
| Selventa | United States |
| Senesco Technologies, Inc | United States |
| Senn Chemicals AG | United States |
| Sensor Pharma | United States |
| Sensorin | United States |
| sequel venture partners | United States |
| Sequella, Inc. | United States |
| Sernova Corp | Canada |
| SERVIER | France |
| SFJ Pharma | United States |
| SGS Life Science Services | United States |
| Shenyang Aihui Biotechnology Co.,Ltd | China |
| Sherbrook Capital Management | United States |
| Shield Corporate Finance Ltd | United Kingdom |
| Shield Therapeutics | United Kingdom |
| Shionogi Inc. | United States |
| Shire Pharmaceuticals | United States |
| Sialix Inc | United States |
| Sichenzia, Ross, Friedman & Ference LLP | United States |
| Sikich Investment Banking | United States |
| Silence Therapeutics | United Kingdom |
| Silicon Valley Bank | United States |
| Siloam Biosciences, Inc | United States |
| Sirius Genomics | Canada |
| SIRO Clinpharm | United States |
| SNN Incorporated | United States |
| Socius Advisory, LLC | United States |
| Sofinnova Ventures | Japan |
| Solvay - Peptisyntha | United States |
| SOM Biotech | Spain |
| Special Situations Funds | United States |
| Spencer Trask Ventures | United States |
| Spherix Incorporated | United States |
| Spinifex Pharmaceuticals Pty Ltd | Australia |
| SR One | United States |
| Stabilitech Ltd | United Kingdom |
| Stansberry Research | United States |
| STATKING Clinical Services | United States |
| Stellar Biotechnologies, Inc. | United States |
| StemCells, Inc. | United States |
| StemRD Inc. | United States |
| STJ Advisors LLP | United Kingdom |
| Streetwise Reports LLC | United States |
| Sunstone Capital - Life Science Ventures | Denmark |
| SuperNova Diagostics, Inc. | United States |
| SuppreMol GmbH | Germany |
| SuviCa | United States |
| SV Life Sciences | United Kingdom |
| Swiss Biotech Association | Switzerland |
| Symbios Medical Products | United States |
| Synergy Ventures | United States |
| Synergys Biotherapeutics, Inc. | United States |
| Syngenta Ventures | United States |
| Syntaxin Ltd | United Kingdom |
| Synteract, Inc. | United States |
| Syzygy Therapeutics | United States |
| T | Top of Page |
| Takeda Pharmaceutical Compnay Limited | Japan |
| Tandem Labs | United States |
| Targacept | United States |
| Target Health Inc. | United States |
| Tavistock | United States |
| Tech Coast Angels | United States |
| Technology Aquisition Group | United States |
| Tectra | Denmark |
| Teikoku Phama USA Inc | United States |
| Tekesta Capital | United States |
| Teleflex | United States |
| Telome Health, Inc. | United States |
| Telormedix SA | Switzerland |
| Tengion | United States |
| Teralys Capital Inc. | Canada |
| Tethys Bioscience, Inc. | United States |
| Thallo Bioscience Advisors, LLC | United States |
| The Channel Group, LLC | United States |
| The Economist/Freelance | United States |
| The Invus Group, LLC | United States |
| The Irvine Group | United States |
| The Scripps Research Institute | United States |
| TheBioTechPanel.com | United States |
| Therapure Biopharma Inc. | Canada |
| TheStreet | United States |
| Thiel Foundation | United States |
| Third Security, LLC | United States |
| Thomas, McNerney & Partners | United States |
| Thompson Hine | United States |
| Thorne Research | United States |
| Threshold Pharmaceuticals | United States |
| Tiberend Strategic Advisors, Inc. | United States |
| TiGenix | Belgium |
| Timeless Wealth | Canada |
| Tissue Genesis, Inc. | United States |
| TONIX Pharmaceuticals | United States |
| Torreya Partners | United States |
| Toucan Capital | United States |
| Toxikon corporation | United States |
| TPP Global Development Limited | United Kingdom |
| TRACON Pharma | United States |
| TRI State Ventures LLC | United States |
| TriMod Therapeutics | Ireland |
| TriNet | United States |
| TRION Pharma GmbH | Germany |
| Triple G Associates | United States |
| U | Top of Page |
| U.S Preventive Medicine | United States |
| U.S. Commercial Service | United States |
| Ubifrance | United States |
| UKTI | United Kingdom |
| Unicorn | United States |
| Unigene Laboratories | United States |
| Uniseed Management Pty ltd | Australia |
| Unizyme Laboratories | Denmark |
| Upstart | United States |
| US Department of Health and Human Services Region IX | United States |
| USC Stevens Institute for Innovation | United States |
| V | Top of Page |
| Valley Fever Solutions | United States |
| van der Walde & Co. | United States |
| Vapogenix, Inc. | United States |
| Vascular Designs | United States |
| Vatera Healthcare | United States |
| Vaxiion Therapeutics, Inc. | United States |
| Vectron Biosolutions | Norway |
| Ventria Bioscience | United States |
| VentriNova, Inc. | United States |
| Venture Valuation | Switzerland |
| Ventures West Capital Ltd. | Canada |
| Versi Group LLC | United States |
| Vetter Pharma | United States |
| ViciBio Pty Ltd | Australia |
| Vicus Therapeutics, LLC | United States |
| Virdispharma | United Kingdom |
| Vista Capital Investments, LLC | United States |
| VIVALIS | France |
| Vivo Venture | United States |
| Vogel BioC | Switzerland |
| Vybion, Incs | United States |
| W | Top of Page |
| Warburg Pincus Asia | China |
| Watching Mountain Capital | United States |
| Waterstone Pharma | United States |
| WBB Securities LLC | United States |
| Wellington Partners | Germany |
| Wexford Press | United States |
| Wilson Sonsini Goodrich & Rosati | United States |
| Wombat Capital Ltd. | United States |
| Women in Bio | United States |
| Woodside Capital Partners | United States |
| X | Top of Page |
| Xalud Therapeutics, Inc. | United States |
| XBiotech | United States |
| Xcelience LLC | United States |
| Xention Ltd | United Kingdom |
| XOMA | United States |
| Xplico A/S | Denmark |
| Y | Top of Page |
| Yasuda Enterprise Development Co., Ltd. | Japan |
| YOH Services | United States |
| Yorkville Advisors | United States |
| Your Bio Team | United States |
| Yuuwa Capital LP | Australia |
| Z | Top of Page |
| Zacks Equity Research | United States |
| Zalicus Inc. | United States |
| Zarzatech | United States |
| ZephyrBiotech, LLC | United States |
| Zora Biosciences Oy | Finland |
| Zymeworks Inc. | Canada |
